Neurocrine Biosciences, Inc.Neurocrine Biosciences, Inc.Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc.

No trades
See on Supercharts

Price target

168.790.000.00%
The 24 analysts offering 1 year price forecasts for NBIX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 28 analysts giving stock ratings to NBIX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NBIX EPS for the last quarter is 0.63 USD despite the estimation of 1.13 USD. In the next quarter EPS is expected to reach 1.54 USD. Track more of Neurocrine Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Neurocrine Biosciences, Inc. revenue is expected to reach ‪604.85 M‬ USD. Check out Neurocrine Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, NBIX price target is 168.79 USD with a max estimate of 204.00 USD and a min estimate of 128.00 USD. Check if this forecast comes true in a year, meanwhile watch Neurocrine Biosciences, Inc. stock price chart and keep track of the current situation with NBIX news and stock market news.
We've gathered opinions of 28 analysts rating NBIX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.